Potential brain cancer cure advances to clinical trial

A 'supercharged' version of QIMR Berghofer's CMV-specific T cell immunotherapy for brain cancer has advanced to a phase 1 clinical trial with CUREator funding.

Related Keywords

Australia ,Australian ,David Walker ,Paulo Martins ,Australian Government Medical Research Future Fund ,Berghofer Tumour Immunology Group ,Newro Foundation ,Berghofer Research ,Australian Government ,Medical Research Future Fund ,Tumour Immunology Group ,Professor Rajiv Khanna ,Professor David Walker ,Briz Brain ,Chimeric Antigen Receptors ,Research Officer Dr Paulo Martins ,Q Gen Cell ,Immunotherapy ,Cureator ,Rain Cancer Cure ,Qimr Berghofer ,Yteph ,Glioblastoma ,Erff ,Riz Brain Amp Spine ,